Literature DB >> 3040412

Probing of the structural stability of vimentin and desmin-type intermediate filaments with Ca2+-activated proteinase, thrombin and lysine-specific endoproteinase Lys-C.

G Perides, S Kühn, A Scherbarth, P Traub.   

Abstract

Intermediate filaments (IFs) reconstituted from purified, delipidated vimentin and desmin as well as respective protofilaments were subjected to degradation by Ca2+-activated neutral thiol proteinase, thrombin and lysine-specific endoproteinase Lys-C, respectively. The breakdown products were analyzed by SDS-polyacrylamide gel electrophoresis and negative stain electron microscopy. While Ca2+-activated proteinase and thrombin caused rapid and complete degradation of IFs with kinetics not significantly different from those of the degradation of protofilaments, lysine-specific endoproteinase did not exert any electron microscopically detectable effect on filament structure. Although both types of subunit proteins were truncated at their non-alpha-helical, C-terminal polypeptides by this proteinase, they were still able to assemble into 10 nm filaments. Closer electron microscopic inspection of IFs treated with Ca2+-activated proteinase revealed numerous ruptures along the filaments already at very early stages of digestion. SDS-polyacrylamide gel electrophoresis of the processed filaments in conjunction with previous biochemical characterizations of the breakdown of protofilaments by Ca2+-activated proteinase showed that these inhomogeneities primarily arose from degradation of the arginine-rich, non-alpha-helical N-termini of the filament proteins. These findings demonstrate that, although the N-terminus of vimentin and desmin is essential for filament stability, it is still highly susceptible to proteolytic attack in particular and very likely to posttranslational modification in general. Such structural modifications of the N-termini of IF proteins might exert great influences on the intracellular distribution and molecular organization of IFs in various physiological and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040412

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  7 in total

1.  Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides.

Authors:  Annunziata Lapolla; Domenico Fedele; Rachele Reitano; Nadia Concetta Aricò; Roberta Seraglia; Pietro Traldi; Ester Marotta; Roberto Tonani
Journal:  J Am Soc Mass Spectrom       Date:  2004-04       Impact factor: 3.109

2.  Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

3.  Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein.

Authors:  R L Shoeman; B Höner; T J Stoller; C Kesselmeier; M C Miedel; P Traub; M C Graves
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  Cytoskeleton-associated plectin: in situ localization, in vitro reconstitution, and binding to immobilized intermediate filament proteins.

Authors:  R Foisner; F E Leichtfried; H Herrmann; J V Small; D Lawson; G Wiche
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

5.  Integrating the actin and vimentin cytoskeletons. adhesion-dependent formation of fimbrin-vimentin complexes in macrophages.

Authors:  I Correia; D Chu; Y H Chou; R D Goldman; P Matsudaira
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

6.  The roles of the rod end and the tail in vimentin IF assembly and IF network formation.

Authors:  M B McCormick; P Kouklis; A Syder; E Fuchs
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

7.  A potential role for the COOH-terminal domain in the lateral packing of type III intermediate filaments.

Authors:  P D Kouklis; T Papamarcaki; A Merdes; S D Georgatos
Journal:  J Cell Biol       Date:  1991-08       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.